When an independent replication isn’t really independent

Matt Warman

My laboratory at Boston Children’s Hospital and Harvard Medical School studies genetic diseases that affect the skeletal system.  We became interested in the protein osteocalcin after Gerard Karsenty at Columbia University reported in several papers using knockout mice – mice lacking the genes which produce osteocalcin – that osteocalcin is a bone-derived hormone that affects glucose metabolism, insulin production, male fertility, muscle mass, and cognition.  If osteocalcin functions similarly in humans, then osteocalcin becomes an exciting and clinically important protein. 

To independently confirm these findings, we created our own osteocalcin knockout mouse strain. We examined glucose metabolism and male fertility in our mice and found none of the effects reported by Karsenty and colleagues; we reported our findings in May 2020.  A group in Japan created a third osteocalcin knockout mouse strain which also failed to confirm Karsenty and colleagues’ findings.  

In earlier years my laboratory also could not independently confirm other results reported by the Karsenty group: a paper I co-authored in 2011 found no evidence of the Wnt co-receptor LRP5 affecting blood serotonin levels, contrary to what Karsenty’s lab published.

Continue reading When an independent replication isn’t really independent

Papers in Croce case with “blatantly obvious” problems still aren’t retracted after misconduct investigation: sleuth

Carlo Croce

This week, Nature reported on two institutional reports that found scientists in Carlo Croce’s cancer research lab at The Ohio State University had committed research misconduct including plagiarism and data falsification. 

Another institutional investigation directed at Croce did not find he committed research misconduct but did identify problems with how he managed his lab, according to Nature

It’s the latest chapter in a years-long saga of mounting numbers of corrections and retractions for Croce, a 2017 article in the New York Times that brought him to widespread attention, a scientist sleuth trying to clean up the literature, and lots and lots of lawyers, some of whom may have a claim  on Croce’s house after he didn’t pay his legal bills.

Continue reading Papers in Croce case with “blatantly obvious” problems still aren’t retracted after misconduct investigation: sleuth

UPenn prof with four retractions “may no longer be affiliated” with school

William Armstead

A pharmacology researcher with four retractions appears to have left the University of Pennsylvania, where he had worked for at least 30 years and won more than $7 million in NIH grants.

The school’s faculty page for William Armstead, who held ​​a research professorship in Anesthesiology and Critical Care, now bears only the statement that “Dr. Armstead may no longer be affiliated with the Perelman School of Medicine.” Penn Medicine has not responded to our request for comment.  

In May, we reported that Armstead was up to four retractions after the Journal of Neurotrauma had retracted three articles at the researcher’s request. 

Continue reading UPenn prof with four retractions “may no longer be affiliated” with school

University of Rochester cancer researchers included ‘incorrect images’ in 13 papers, committee finds

Yuhchyau Chen

A group of cancer researchers at the University of Rochester have now lost three papers over concerns about the data in the articles – issues that evidently did not rise to the level of misconduct, according to the institution.

The work came from the lab of Yuhchyau Chen, of the university’s Wilmot Cancer Institute. A common co-author was Soo Ok Lee, who is no longer affiliated with the University of Rochester. In addition to the three retractions, Lee has several corrections and an expression of concern.

The most recent retraction involves a 2019 article in the Journal of Molecular Medicine titled “Radiation-induced glucocorticoid receptor promotes CD44 + prostate cancer stem cell growth through activation of SGK1-Wnt/β-catenin signaling” for which Chen and Lee were corresponding authors. The paper has been cited nine times, according to Clarivate Analytics’ Web of Science.

According to the retraction notice, dated December 10:  

Continue reading University of Rochester cancer researchers included ‘incorrect images’ in 13 papers, committee finds

Widely covered paper on ranitidine-cancer link retracted

ParentingPatch via Wikimedia

A paper linking the use of a wildly popular drug for heartburn to cancer has been retracted after the authors concluded that their widely touted finding appears to have resulted from a hiccup in the way they conducted their testing. 

The 2016 article, in Carcinogenesis, has played a minor role in an ongoing class action lawsuit against the makers of ranitidine (sold as Zantac, among other brand names) claiming that use of the medication has caused cancer in more than 100,000 plaintiffs. And it was a key citation in a 2019 petition to the FDA urging that such drugs be recalled.

The FDA has been investigating contamination of ranitidine and a related drug with NDMA, a known human carcinogen at high doses. On April 1, 2020, the agency announced that, although its tests did not find concerning levels of NDMA in “many” of the samples it tested, it was recalling all products that contain ranitidine:

Continue reading Widely covered paper on ranitidine-cancer link retracted

Kentucky professor resigns ahead of vote that could have stripped him of tenure

Xianglin Shi

A former endowed professor at the University of Kentucky has resigned from the faculty days before a committee at the institution was scheduled to vote on whether to fire him for misconduct, Retraction Watch has learned. 

In 2018, the university began investigating Xianglin Shi, a toxicologist and cancer biologist who that year, as we reported then, lost three papers in the Journal of Biological Chemistry for image manipulation. At the time, Shi was the principal investigator of a 5-year, $7.4 million grant from the National Institute of Environmental Health Sciences to establish the UK Center for Appalachian Research in Environmental Sciences (UK-CARES).

In the wake of the retractions, Shi was stripped of his title as the William A. Marquard Chair in Cancer Research and his role as associate dean for research integration in the UK College of Medicine. 

Continue reading Kentucky professor resigns ahead of vote that could have stripped him of tenure

“Serious non-compliance” prompts retraction of book on social justice in Hawai’i

A publisher retracted a book last year after the home institution of one of the editors, the University of Hawai’i, “identified research protocol violations by two of the editors, which constitute Serious Non-Compliance.”

The 2019 book, Voices of Social Justice and Diversity in a Hawai‘i Context, was edited by Amarjit Singh and Mike Devine, of Memorial University in Newfoundland, and M. Luafata Simanu-Klutz of the University of Hawai’i.

According to the book’s description, it:

Continue reading “Serious non-compliance” prompts retraction of book on social justice in Hawai’i

Litigious OSU cancer researcher earns his 10th retraction

Carlo Croce

Carlo Croce, the prolific cancer researcher at The Ohio State University (OSU) with a penchant for hiring — and then losing — lawyers to sue those who displease him, has lost an 10th paper to retraction.

Croce, who in addition to the 10 retractions also has three expressions of concern and 18 corrections for his work, unsuccessfully sued the New York Times for defamation after the newspaper reported on misconduct allegations against him. He has also sued OSU — also unsuccessfully — to force them to restore him as chair of the Department of Cancer Biology and Genetics. 

Apparently, Croce and his co-author thought that a correction to the newly retracted article was necessary because of “improper reuse of text from previous articles.” The journal, however, felt differently.

Continue reading Litigious OSU cancer researcher earns his 10th retraction

Four retractions follow misconduct inquiry at U Maryland

via Wikimedia

The Journal of Virology has retracted three papers, and corrected two others, by a group led by a researcher at the University of Maryland, for problematic images. 

The articles, published in 2008 and 2014, describe experiments to assess the immune response to Newcastle disease virus in various animal species.  The studies were led by Siba K. Samal, a molecular biologist at the Virginia-Maryland Regional College of Veterinary Medicine at the University of Maryland, in College Park.

The retractions make four for Samal, who also lost a 2015 paper in the Journal of Clinical Microbiology, “Glycoprotein-based enzyme-linked immunosorbent assays for serodiagnosis of infectious laryngotracheitis,” and whose work has been scrutinized on PubPeer for more than four years. The notice for that paper reads: 

Continue reading Four retractions follow misconduct inquiry at U Maryland

Fourth retraction for Haruko Obokata, focus of STAP cell scandal, after Harvard investigation

Charles Vacanti

More than five years after Nature retracted two highly suspect papers about what had been described as a major breakthrough in stem cell research, another journal has pulled a paper about the work. 

The scandal over so-called STAP stem cells took down more than just a few articles. The case centered on Haruko Obokata, a Japanese researcher who conducted the studies as a post-doc in the Harvard lab of Charles Vacanti. Obokata lost her doctoral thesis from Waseda University in 2015 because it plagiarized from the U.S. National Institutes of Health. She also retracted a paper in Nature Protocols

Continue reading Fourth retraction for Haruko Obokata, focus of STAP cell scandal, after Harvard investigation